P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
Introduction and Objectives: Primary sclerosing cholangitis (PSC) is a cholestatic disease that commonly affects young males with inflammatory bowel disease (IBD). There is no efficient medical treatment, being orthotopic liver transplantation (OLT) the only curative treatment recommended in decompe...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268123000832 |
| _version_ | 1827981894580436992 |
|---|---|
| author | Diogo Delgado Dotta Marcus Vinicius De Acevedo Garcia Gomes Ana Elisa Rabe Caon Davi Viana Ramos Luisa Leite Barros Débora Raquel Benedita Terrabuio Eduardo Luiz Rachid Cançado |
| author_facet | Diogo Delgado Dotta Marcus Vinicius De Acevedo Garcia Gomes Ana Elisa Rabe Caon Davi Viana Ramos Luisa Leite Barros Débora Raquel Benedita Terrabuio Eduardo Luiz Rachid Cançado |
| author_sort | Diogo Delgado Dotta |
| collection | DOAJ |
| description | Introduction and Objectives: Primary sclerosing cholangitis (PSC) is a cholestatic disease that commonly affects young males with inflammatory bowel disease (IBD). There is no efficient medical treatment, being orthotopic liver transplantation (OLT) the only curative treatment recommended in decompensated cirrhosis, intractable pruritus and recurrent cholangitis. Objectives: Describe clinical, laboratory and histological findings in patients with PSC-IBD of a quaternary hospital and identify prognostic factors for OLT. Materials and Methods: Review of patients’ medical records with PSC-IBD followed from 01/2000 to 05/2022, excluding cases with insufficient data. Results: Among 73 patients, 57% were male; the mean age during PSC diagnosis was 34,2±14,3 years, with a follow-up period of 8,8±5.4 years, 85% of those presenting ulcerative colitis. During diagnosis, 93% were symptomatic, usually presenting with pruritus and fatigue. A liver biopsy was performed in 30 patients, and 60% of those revealed F3/4. 4 patients presented dominant strictures (DS) and 68 were treated with ursodeoxycholic acid (UDCA) 16mg/kg/d. 16 (21.9%) underwent OLT in a period of 6.3±4,5 years after diagnosis; the main indication was decompensated cirrhosis. Ten patients had cancer, and the two most frequent were colorectal carcinoma and cholangiocarcinoma. 13 patients died; from those, four were transplanted and six died of infection. Between patients with and without OLT, there were no significant differences in age during diagnosis, type of IBD, comorbidities, presence of symptoms during diagnosis, histological fibrosis, or presence of DS. The OLT group had higher levels of bilirubin (3 × 0,8mg/dL;p<0,001) and lower albumin levels (3,4 × 4,3g/dL;p<0,001) during diagnosis. They also presented higher levels of alkaline phosphatasis (394 × 223U/L;p<0,001) and lower frequency of normalization (0 × 30%;p=0,027) after 6-month treatment with UDCA. Conclusions: Higher levels of bilirubin and lower albumin during diagnosis and higher levels of alkaline phosphatasis after 6-month treatment with UDCA were associated with an increased risk of disease progression for OLT. |
| first_indexed | 2024-04-09T22:15:02Z |
| format | Article |
| id | doaj.art-61412be83c514c0c8f2f7503bfdb99c7 |
| institution | Directory Open Access Journal |
| issn | 1665-2681 |
| language | English |
| last_indexed | 2024-04-09T22:15:02Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Annals of Hepatology |
| spelling | doaj.art-61412be83c514c0c8f2f7503bfdb99c72023-03-23T04:34:17ZengElsevierAnnals of Hepatology1665-26812023-03-0128100979P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASEDiogo Delgado Dotta0Marcus Vinicius De Acevedo Garcia Gomes1Ana Elisa Rabe Caon2Davi Viana Ramos3Luisa Leite Barros4Débora Raquel Benedita Terrabuio5Eduardo Luiz Rachid Cançado6University of São Paulo School of Medicine, Clinics Hospital, São Paulo, BrazilUniversity of São Paulo School of Medicine, Clinics Hospital, São Paulo, BrazilUniversity of São Paulo School of Medicine, Clinics Hospital, São Paulo, BrazilUniversity of São Paulo School of Medicine, Clinics Hospital, São Paulo, BrazilUniversity of São Paulo School of Medicine, Clinics Hospital, São Paulo, BrazilUniversity of São Paulo School of Medicine, Clinics Hospital, São Paulo, BrazilUniversity of São Paulo School of Medicine, Clinics Hospital, São Paulo, BrazilIntroduction and Objectives: Primary sclerosing cholangitis (PSC) is a cholestatic disease that commonly affects young males with inflammatory bowel disease (IBD). There is no efficient medical treatment, being orthotopic liver transplantation (OLT) the only curative treatment recommended in decompensated cirrhosis, intractable pruritus and recurrent cholangitis. Objectives: Describe clinical, laboratory and histological findings in patients with PSC-IBD of a quaternary hospital and identify prognostic factors for OLT. Materials and Methods: Review of patients’ medical records with PSC-IBD followed from 01/2000 to 05/2022, excluding cases with insufficient data. Results: Among 73 patients, 57% were male; the mean age during PSC diagnosis was 34,2±14,3 years, with a follow-up period of 8,8±5.4 years, 85% of those presenting ulcerative colitis. During diagnosis, 93% were symptomatic, usually presenting with pruritus and fatigue. A liver biopsy was performed in 30 patients, and 60% of those revealed F3/4. 4 patients presented dominant strictures (DS) and 68 were treated with ursodeoxycholic acid (UDCA) 16mg/kg/d. 16 (21.9%) underwent OLT in a period of 6.3±4,5 years after diagnosis; the main indication was decompensated cirrhosis. Ten patients had cancer, and the two most frequent were colorectal carcinoma and cholangiocarcinoma. 13 patients died; from those, four were transplanted and six died of infection. Between patients with and without OLT, there were no significant differences in age during diagnosis, type of IBD, comorbidities, presence of symptoms during diagnosis, histological fibrosis, or presence of DS. The OLT group had higher levels of bilirubin (3 × 0,8mg/dL;p<0,001) and lower albumin levels (3,4 × 4,3g/dL;p<0,001) during diagnosis. They also presented higher levels of alkaline phosphatasis (394 × 223U/L;p<0,001) and lower frequency of normalization (0 × 30%;p=0,027) after 6-month treatment with UDCA. Conclusions: Higher levels of bilirubin and lower albumin during diagnosis and higher levels of alkaline phosphatasis after 6-month treatment with UDCA were associated with an increased risk of disease progression for OLT.http://www.sciencedirect.com/science/article/pii/S1665268123000832 |
| spellingShingle | Diogo Delgado Dotta Marcus Vinicius De Acevedo Garcia Gomes Ana Elisa Rabe Caon Davi Viana Ramos Luisa Leite Barros Débora Raquel Benedita Terrabuio Eduardo Luiz Rachid Cançado P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE Annals of Hepatology |
| title | P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE |
| title_full | P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE |
| title_fullStr | P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE |
| title_full_unstemmed | P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE |
| title_short | P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE |
| title_sort | p 85 higher levels of alkaline phosphatasis after 6 month treatment with ursodeoxycholic acid were associated with evolution to orthotopic liver transplantation in patients with primary sclerosing cholangitis and inflammatory bowel disease |
| url | http://www.sciencedirect.com/science/article/pii/S1665268123000832 |
| work_keys_str_mv | AT diogodelgadodotta p85higherlevelsofalkalinephosphatasisafter6monthtreatmentwithursodeoxycholicacidwereassociatedwithevolutiontoorthotopiclivertransplantationinpatientswithprimarysclerosingcholangitisandinflammatoryboweldisease AT marcusviniciusdeacevedogarciagomes p85higherlevelsofalkalinephosphatasisafter6monthtreatmentwithursodeoxycholicacidwereassociatedwithevolutiontoorthotopiclivertransplantationinpatientswithprimarysclerosingcholangitisandinflammatoryboweldisease AT anaelisarabecaon p85higherlevelsofalkalinephosphatasisafter6monthtreatmentwithursodeoxycholicacidwereassociatedwithevolutiontoorthotopiclivertransplantationinpatientswithprimarysclerosingcholangitisandinflammatoryboweldisease AT davivianaramos p85higherlevelsofalkalinephosphatasisafter6monthtreatmentwithursodeoxycholicacidwereassociatedwithevolutiontoorthotopiclivertransplantationinpatientswithprimarysclerosingcholangitisandinflammatoryboweldisease AT luisaleitebarros p85higherlevelsofalkalinephosphatasisafter6monthtreatmentwithursodeoxycholicacidwereassociatedwithevolutiontoorthotopiclivertransplantationinpatientswithprimarysclerosingcholangitisandinflammatoryboweldisease AT deboraraquelbeneditaterrabuio p85higherlevelsofalkalinephosphatasisafter6monthtreatmentwithursodeoxycholicacidwereassociatedwithevolutiontoorthotopiclivertransplantationinpatientswithprimarysclerosingcholangitisandinflammatoryboweldisease AT eduardoluizrachidcancado p85higherlevelsofalkalinephosphatasisafter6monthtreatmentwithursodeoxycholicacidwereassociatedwithevolutiontoorthotopiclivertransplantationinpatientswithprimarysclerosingcholangitisandinflammatoryboweldisease |